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AbsTrACT
background Putative nucleotidyltransferase MaB21l1 
is a member of an evolutionarily well-conserved family 
of the male abnormal 21 (MaB21)-like proteins. little 
is known about the biochemical function of the protein; 
however, prior studies have shown essential roles for 
several aspects of embryonic development including the 
eye, midbrain, neural tube and reproductive organs.
Objective a homozygous truncating variant in 
MAB21L1 has recently been described in a male 
affected by intellectual disability, scrotal agenesis, 
ophthalmological anomalies, cerebellar hypoplasia 
and facial dysmorphism. We employed a combination 
of exome sequencing and homozygosity mapping 
to identify the underlying genetic cause in subjects 
with similar phenotypic features descending from five 
unrelated consanguineous families.
results We identified four homozygous 
MAB21L1 loss of function variants (p.glu281fs*20, 
p.arg287glufs*14 p.tyr280* and p.Ser93Serfs*48) 
and one missense variant (p.gln233Pro) in 10 affected 
individuals from 5 consanguineous families with a 
distinctive autosomal recessive neurodevelopmental 
syndrome. cardinal features of this syndrome include 
a characteristic facial gestalt, corneal dystrophy, hairy 
nipples, underdeveloped labioscrotal folds and scrotum/
scrotal agenesis as well as cerebellar hypoplasia with 
ataxia and variable microcephaly.
Conclusion this report defines an ultrarare but 
clinically recognisable cerebello-Oculo-Facio-genital 
syndrome associated with recessive MAB21L1 variants. 
additionally, our findings further support the critical 
role of MaB21l1 in cerebellum, lens, genitalia and as 
craniofacial morphogenesis.
InTrODuCTIOn
MAB21l1 belongs to the conserved male abnormal 
gene family 21 (mab21). First described in the 
nematode Caenorhabditis elegans as a transcription 
factor in cell fate determination,1 the family consists 
of three members, namely mab21l1, mab21l2 and 
mab21l3 in vertebrates. Mab21 genes play a major 
role in embryonic development but gene expression 
extends beyond the developmental period well into 
adulthood.2 Molecular explorations in C. elegans, 
Danio rerio, Xenopus tropicalis and mice indicate a 
crucial role for Mab21 family members in diverse, 
developmentally important cell signalling path-
ways, including TGF-B/BMP, JNK1/MKK4, PAX6. 
Members of these pathways have been previously 
shown to play an important role for lens develop-
ment and their expression patterns correlate with 
different Hox genes.3–5
Protein modelling of Mab21L1 and Mab21L2 
in vertebrates shows 94% identical amino acid 
sequences, raising the possibility of partially 
redundant gene function.6 Likewise, Mab21l1 
and Mab21l2 expression patterns in vertebrates 
are partially overlapping in the developing eye, 
midbrain, branchial arches and limb buds.3 Both 
Mab21l1 and Mab21l2 depleted mouse embryos 
show severe defects in development of the noto-
chord, neural tube and organogenesis, vasculogen-
esis and axial turning.7 Intriguingly, Mab21l1-/- mice 
have defects only in ocular development and 
preputial glands and very recently demonstrated 
an unclosed calvarium.4 8 Hypomorphic mab21 
C. elegans mutants develop a short and fat body, 
uncoordinated movement and reduced fertility in 
addition to defects in sensory rays.9 In humans, 
recessive MAB21L2 alleles have been associated 
with a range ocular malformations such as micro-
phthalmia/anophthalmia, coloboma, with skeletal 
dysplasias and intellectual disability (ID).10 11
Recently, a truncating MAB21L1 variant 
(c.735dupG; p.Cys246Leufs*18) was identified in 
a male affected with ID, scrotal agenesis, ophthal-
mological anomalies, cerebellar malformation and 
facial dysmorphism.12 Of note, this extremely 
rare combination of clinical findings was previ-
ously reported in four patients from two families 
in the literature.13 Comparison of phenotypic data 
between the reported cases and the MAB21L1 index 
case may suggest a common syndrome; however, 
no molecular investigations were reported in those 
families.
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Here, we now report novel biallelic variants in 10 patients 
from five independent families with Cerebello-Oculo-Facio-Gen-
ital (COFG) syndrome, confirming MAB21L1 loss of function is 
the underlying cause for this ultrarare hereditary disorder.
MATerIAl AnD MeThODs
subjects
Recruitment criteria to the study were syndromic labioscrotal 
aplasia and/or cerebellar hypoplasia with eye/genital anomalies. 
DNA samples were collected after obtaining informed patient 
or parental consent as part of the clinical diagnostic pathway 
at Radboud University Medical Center Nijmegen (Innovative 
Diagnostic Programme), as part of the clinical genetics diag-
nostic pathway at Inova Fairfax Hospital, Falls Church, Virginia, 
USA, Laboratory for Paediatric Brain Disease, Howard Hughes 
Medical Institute, Rady Children's Institute for Genomic Medi-
cine, University of California, San Diego, California, USA, 
Department of Neurosurgery, Program on Neurogenetics, Yale 
School of Medicine, Yale University, New Haven, Connecticut, 
USA and Istanbul Koc University or as part of a research study 
with the approval of the Institutional Ethics Review Board 
(approval number KUSoM; 2015.120.IRB2.047 CRANIRA-
RE-2,HIC # 94060007680).
exome sequencing (es)
Exomic sequences from DNA samples of family 1 were enriched 
with the SureSelect Human All Exon 50 Mb V.6 Kit (Agilent 
Technologies, Santa Clara, California, USA) Kit (families 1, 4 
and 5) and exonic regions and flanking splice junctions of the 
genome were captured using a proprietary system developed by 
GeneDx (Gaithersburg, Maryland, USA) for family 2. For family 
3, Nextera Rapid Capture Exome Kit (Illumina, San Diego, Cali-
fornia, USA) was used for exome capture. 100 bp paired-end 
reads were generated either on Hiseq PE150 (Illumina) or using 
a HiSeq2000 or HiSeq4000 with paired end analysis. Image 
analysis and subsequent base calling was performed using the 
Illumina pipeline (V.1.8). Read alignment and variant calling 
were performed with DNAnexus (Palo Alto, California, USA) 
using default parameters with the human genome assembly hg19 
(GRCh37) as reference for families 1, 2 and 4. For family 3, a 
Centogene in-house pipeline previously described was used for 
variant calling instead14 while likewise for family 5, we used a 
different in-house written variant calling pipeline as described 
previously.15 Briefly, sequence reads were mapped to the human 
genome reference sequence (version GRCh37, as used in phase 
1 of the 1000 Genomes Project) using a hybrid of Stampy16 
and BWA.17 For all five families, variant calling of SNVs and 
small indels was accomplished using the Unified Genotyper 
algorithm from GATK.18 Variant alleles were annotated using 
Ensembl database (V.66) and Variant Effect Predictor (V.2.4) 
tool.19 Following alignment and variant calling, serial variant 
filtering was performed for variants a MAF equal or less than 
0.5% for families 1–3 and less than 0.1% for families 4 and 5 
inExAc, 1000 genome project, esp6500 databases and gnomad. 
For family 5, an additional in-house exome database for Turkish 
exomes was used. Coding variants include frameshift, stop 
and variants changing the protein structure using scores from 
SIFT (Sorting Intolerant From Tolerant; http:// sift. bii. a- star. 
edu. sg), PolyPhen (http:// genetics. bwh. harvard. edu/ pph2) and 
GERP++ (Genomic Evolutionary Rate Profiling; http:// mendel. 
stanford. edu/ SidowLab/ downloads/ gerp) or variants within 5 bp 
of exon-intron boundaries and genes carrying biallelic variants 
with prioritisation of homozygous variants in consanguineous 
pedigrees and genes with compound variants in non-consan-
guineous pedigrees. Obligate loss of function variants such as 
canonical splice variants, frameshift and stop mutations were 
prioritised over missense variants; however, missense variants 
were not excluded from the analysis. For family 2, variants were 
filtered using a custom-developed analysis tool (XomeAnalyzer), 
data were filtered and analysed to identify sequence variants and 
most deletions and duplications involving three or more coding 
exons (GeneDx).
sanger sequencing
Genomic DNA was isolated by standard methods directly from 
blood samples using a standard DNA extraction kit (Qiagen, 
USA). Amplification of genomic DNA was performed in a volume 
of 50 µl containing 30 ng DNA, 50 pmol of each primer, 2 mM 
dNTPs and 1.0 U GoTaq DNA polymerase (Promega Corpora-
tion, #M3001) or 1.0 U MolTaq polymerase (Molzym Corpora-
tion, #P-016). PCR amplifications were carried out by an initial 
denaturation step at 94°C for 3 min and 33 cycles as follows: 
94°C for 30 s, 58–60°C for 30 s and 72°C for 70 s, with a final 
extension at 72°C for 10 min. PCR products were verified by 
agarose gel electrophoresis, purified and sequenced bidirection-
ally. The sequence data were evaluated using the CodonCode 
or Sequencher 4.9 (Gene Codes) software. Primer sequences are 
available on request.
Genomic snP array
Genome-wide single nucleotide varaint (SNP) array analysis 
was undertaken in families 1 and 2 using either Illumina Global 
Screening Array (Neuherberg, Germany) (family 1) or postnatal, 
Oligo-SNP array Quest Diagnostics (Chantilly, Virginia, USA) 
(family 2) according to the manufacturer’s protocol (http://
www. illumina. com/ techniques/ microarrays).
string protein-protein interaction network analysis
We used the string protein interaction network online tool at 
https:// string- db. org/20 to search for Mab21l1 binding partners. 
We chose an analysis setup where only experimentally deter-
mined interaction partners are displayed. Confidence level for 
all interaction proteins was high as defined by String (>0.70).
resulTs
In order to elucidate the genetic cause of the strikingly similar 
syndromic labioscrotal aplasia phenotype in four consanguin-
eous families, we performed exome sequencing (ES). Clinical 
features are displayed in figure 1 and summarised in table 1.
Family 1 was a large consanguineous family from Iran with 
four affected individuals from two branches, two females and 
two males, aged between 7 months and 17 years. All affected 
individuals were born to healthy consanguineous parents 
following uneventful pregnancies (figure 2). The affected chil-
dren presented with global developmental delay (DD) and/or 
moderate-to-severe ID with speech impairment and behavioural 
abnormalities. Achievement of neurodevelopmental milestones 
was delayed in all affected ones: walking could not be achieved 
until the age of 4 years and 2.5 years. All had poor balance with 
wide-based gait, although this improved considerably with age 
in individual VI:2. The affected sisters spoke only a few words 
and displayed an aggressive behaviour and were diagnosed with 
attention deficit and hyperactivity disorder. Their affected cousin 
had slurred speech with delayed language acquisition around 
5–6 years of age. His behaviour was characterised as initially 
aggressive but then he developed a shy demeanour. All presented 
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Figure 1 clinical phenotype of cOFg individuals harbouring biallelic MaB21l1 loss of function variants. (a–l) Depicted craniofacial dysmorphism, 
medially sparse/flared and laterally extending eyebrows, synophrys, buphthalmos, anteverted nares, long and tented philtrum, flat nasal bridge, low anterior 
hairline and horizontal nystagmus with strabismus (a–D: individuals from family 1; e–H and aa: individual 4_V:1 from 7 years of age to adulthood; i, J, ab: 
individual 5_iV:1 from childhood to adulthood; K, l: individual 4_iV.4 from childhood to adulthood, M: individual 3_ii.3). Widely spaced hypoplastic nipples 
with no noticeable areolae or hyperpigmentation and a tuft of terminal hair extruding from the lactiferous ducts (n: individual 1_Vi:7; O: individual 4_V:1; 
P: 5_iV:4). Undescended testes, bilateral scrotal agenesis with normal median raphe in individual 1_Vi:2 (Q), 4_V:1 (r), 5_iV:4 (S). absence of labia majora 
and small labia minora in individuals 1_Vi:5 (t) and 5_iV:1 (U). corneal opacities in individual 1_Vi:7 (V) and individual 5_iV:1. (V`). cerebellar hypoplasia 
with absence/hypoplasia of the vermis in individuals 2_ii:3 (W,X), 4_V:1 (Z, i_iV.V). Optic atrophy in individual 2_ii:3 (Y). cOFg, cerebello-Oculo-Facio-
genital. 
with similar craniofacial dysmorphism with coarse facies, medi-
ally sparse/flared and laterally extending eyebrows, synophrys, 
buphthalmos, anteverted nares, a long and tented philtrum, flat 
nasal bridge, low anterior hairline and hirsutism. The ophthal-
mological examinations revealed horizontal nystagmus, stra-
bismus, dry eye and bilateral corneal dystrophy (figure 2) with 
poor vision necessitating multiple surgeries. Although head 
circumference measurements were at the lower end of the refer-
ence normal range, height and weight were within normal range 
for age (table 1). Neuroimaging in two affected ones revealed 
cerebello-vermian hypoplasia and mild Dandy-Walker malfor-
mation (figure 1H–M).
The affected males (VI:2 and VI:7) had bilateral agenesis of 
scrotum with normal median raphe, flat and non-rugose perineal 
skin (figure 1). Individual VI:7 had undescended testes of normal 
size and underwent surgery for neoscrotum reconstruction and 
left orchidopexy (figure 1E). Similarly, the two affected sisters 
(VI:5 and VI:6) showed absence of labia majora and small labia 
minora (figure 2F). Individual VI:2 displayed a slightly muscular 
build with prominent trapezius muscles, markedly underdevel-
oped and widely spaced nipples with no visible areolae and a tuft 
of terminal hair extruding from the lactiferous ducts (figure 1G). 
Skeletal, renal, cardiac, dermal or gastrointestinal anomalies 
were not observed. There was no history of seizures, and hearing 
was normal. Karyotype analysis by G-banding and SNP array 
genotyping did not reveal any pathogenic copy number variants. 
A clinical suspicion of mucopolysaccharidosis was ruled out by 
screening for metabolic lysosomal storage disorders in blood and 
urine.
Family 2 was an Iranian family with one affected male and two 
healthy siblings, born to healthy first-cousin parents (figure 2). 
The male index case was born at 38 weeks of gestation via 
elective caesarean section, following a pregnancy complicated 
by late gestational diabetes. The mother had opted for Nonin-
vasive Prenatal Testing due to advanced maternal age of 42, 
which resulted as low-risk for trisomies 13, 18, 21 and sex 
chromosome aneuploidies. At birth, he had a weight of 3.6 kg 
(+0.08 SD), length of 56 cm (+2.23 SDs) and head circumfer-
ence of 34 cm (−0.54 SD). Physical examination revealed a low 
anterior hairline with flared eyebrows, complete scrotal agen-
esis and glanular hypospadias with testes palpable under peri-
neal skin. Karyotyping showed normal male constitution of 
46,XY. Genitourinary and perineal superficial ultrasound did 
not reveal any additional malformations. Serum testosterone, 
17-OH progesterone and cortisol levels were within normal 
range. Limited visual fixation and nystagmus were noted during 
visits to genetics, ophthalmology and neurology clinics. Lack of 
visual fixation, inability to follow a target and a variable, high-
angle esotropia were noted during an ophthalmology examina-
tion at 13 months of age. Corneal examination was remarkable 
for bilateral, subepithelial haze. Fundoscopy showed bilateral 
pigment granularity consistent with early retinal degeneration 
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Figure 2 Pedigrees, MaB21l1 mutation segregation patterns and mutation localisation on cDna and protein level. (a) Pedigrees of four families 
harbouring biallelic MaB21l1 loss-of function variants identified by eS. in total, nine affected individuals were identified. Wildtype alleles are indicated 
by ‘+’, alleles carrying identified variants with ‘ -’. (B) Visualisation of the MAB21L1 gene and cOFg associated alleles identified by us as well as the 
previously identified MaB21l1 allele Bruel et al.12 (c) Schematic overview of localisations of cOFg alleles on protein level. (D) computational structural 
model of human MaB21l1, Visualisation of the aminoacid change identified in family 2 and predicted effect on protein folding/structure and evolutionary 
conservation of the mutated position among species. the variant is predicted to disrupt hydrogen bond formation within the alpha-helix structure, disrupting 
the protein secondary structure. cOFg, cerebello-Oculo-Facio-genital; eS, exomic sequencing.
and bilateral, mild optic atrophy. Brain MRI showed generalised 
cerebellar hypoplasia including the vermis. The optic nerves had 
a mildly thin calibre and a tortuous, redundant appearance. The 
optic chiasm, pituitary stalk, posterior pituitary lobe and ante-
rior pituitary lobe were unremarkable (figure 1). He started to 
walk at 18 months of age, was able to climb stairs up and down 
with assistance and could speak 5–6 words at 26 months of age. 
Growth parameters were normal (table 1).
Family 3 is a Lebanese Shia family with a single affected girl, 
third-born to first-degree cousin parents. The affected’s elder 
sibling was reported to have hydrocephalus and global DD. She 
was born at 38 weeks of gestation, with normal birth parameters. 
At 4 months of age, she was referred to the paediatric clinics due 
to hypotonia, DD and dysmorphic features, comprising a short 
forehead, medially flared, thick eyebrows with long eyelashes, 
strabismus and wide nasal tip with short columella. She had 
bilateral corneal opacities and absence of the labioscrotal folds 
with non-rugose perineal skin and mild clitoral hypertrophy. 
Cranial MRI showed severe cerebellar and vermian hypoplasia 
with a large parietal cyst. A work-up including routine biochem-
ical tests, thyroid function tests, metabolic screening, karyo-
type analysis, echocardiogram and abdominopelvic ultrasound, 
revealed normal results. She had severe gastro-oesophageal 
reflux disease in infancy, which ameliorated with time. Height, 
weight and head circumference at follow-up at 2 years of age 
was 116 cm (−1.70 SD), 20 kg (−1.18 SD) and 50 cm (−1.50 
SD). She was unable to sit unsupported, walk, babble or speak 
words.
Families 4 and 5 represent consanguineous Turkish families 
previously described in detail13: family 4 presented with one 
affected male and family 5 comprised three affected siblings 
(figure 2). All affected ones presented with a previously unre-
ported phenotype leading to the clinical delineation of the 
syndrome, comprising agenesis of labioscrotal folds, distinct 
facial features, nystagmus, corneal dystrophy, low frontal hair-
line, hairy nipples, cerebellar hypoplasia with pontine involve-
ment and global DD and/or ID (figure 1 and table 1). Patient 
7 from family 4 underwent penetrating keratoplasty and extra-
capsular cataract extraction at the ages of 7 and 18 months, 
respectively. He was then followed up regularly, but no further 
operations were performed, and he was functionally blind when 
examined at the age of 18 years. Patients 7 and 8 from Family 
4 were also followed up due to anterior corneal dystrophy with 
opacities, but visual loss was limited, necessitating no operations.
ES was performed on single affected individuals from families 
1 and 5, the affected and an unaffected sister for family 4 and as 
Trio Exomein families 2 and 3. Assuming the disease follows an 
autosomal recessive inheritance in these families due to presence 
of consanguinity and multiple affected siblings, we prioritised 
potentially functional homozygous variants residing within runs 
of homozygosity larger than 1 Mb. These variants were screened 
through publicly available population databases (gnomAD, 
GME, Iranome) and in-house database generated for genetic 
variant frequency in human population. We excluded synony-
mous variants, intronic variants (>5 bp from exon boundaries) 
and variants with >1% minor allele frequency. Homozygous 
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variants were prioritised in consanguineous families; however; 
compound heterozygous variants were not primarily filtered 
out. In families 2 and 3, we further excluded variants also found 
in the exome of a parent in homozygous state and in family 4, all 
variants the unaffected sister was homozygous for were likewise 
excluded.
ES on individual 1_VI:5 identified a novel homozygous trun-
cating variant in MAB21L1 (NM_005584.4, c.841delG, p.Glu-
281Aspfs*20) located within a region of homozygosity (chr13: 
37,227,227–37,247,380, online supplementary figure S1), 
segregating with the disease phenotype in the family. Homozy-
gous variants in other genes detected by ES (online supplemen-
tary table S1) were excluded by Sanger sequencing segregation 
analysis. Parallel Trio -ES analysis in family 2 revealed a novel 
homozygous missense variant (NM_005584.4,c.698 A>C, p.Gl-
n233Pro) in MAB21L1, located within a long stretch of homo-
zygosity (chr.13: 24 737 091–43 447 499, online supplementary 
figure S1). This position is conserved across species21 (figure 2) 
and the variant is predicted to have damaging effects by SIFT, 
MutationTaster and CADD, while PolyPhen, Fathmm and 
PROVEAN predict the change to be benign. Modelling using 
HOPE (http://www. cmbi. ru. nl/ hope/ method/) revealed that the 
mutated residue locates to an alpha-helix and that size difference 
and difference in hydrophobicity is predicted to affect forma-
tion of hydrogen bonds at the mutated position. Further, proline 
disrupts alpha helix formation if not located within the first 
3 residues of the structure. The variant is therefore predicted 
to disrupt the alpha helix which in turn is likely to affect the 
secondary protein structure (HOPE prediction, figure 2).
In family 3, a novel homozygous frameshift mutation in 
MAB21L1 (NM_005584.4, c.279_286delACTGCCCG, 
p.Ser93Serfs*48) was identified in individual of the affected 
child by trio ES analysis.
In family 4, individual V:2 and the healthy sister were inves-
tigated by Whole Exome Sequencing (WES) which uncovered a 
novel homozygous truncating MAB21L1 variant (NM_005584.4, 
c.859delC, p.Arg287Glufs*14) while in individual IV:1 from 
family 5 WES revealed a novel homozygous stop-gain variant in 
MAB21L1 (c.840C>G; p.Tyr280*).
All identified variants were validated and cosegregation anal-
ysis was performed by Sanger sequencing (see online supplemen-
tary figure S2). No other likely pathogenic variants compatible 
with the phenotype were identified in currently known disease-
causing genes in ES data. Variants left after filtering are shown in 
online supplementary table S1 for family 1.
As the function of MAB21L1 has remained rather elusive, 
we proceeded to perform an analysis of putative MAB21L1 
protein interactions via crosstalk visualisation using the String 
Network.20 This revealed connections between MAB21L1 and 
HOX, MEIS1-2 and PBX1-3 genes as well as LMX1B20 in 
addition to its function downstream of Pax6 and upstream of 
FOXE3 (online supplementary figure S3). Mutation in genes 
of those developmental pathways cause a range of other devel-
opmental disorders in mammals (online supplementary table 
S2), providing possible pathomechanistic explanations for the 
phenotype observed as a consequence of MAB21L1 loss of func-
tion in humans.
DIsCussIOn
Congenital malformations of the labioscrotal folds are very rare 
with complete agenesis of the scrotum being one of the rarest. 
Over the past 30 years, there have been only a handful of docu-
mented reports of patients who had congenital agenesis of the 
scrotum without an otherwise identifiable genetic syndrome. 
Bruel et al very recently described a homozygous loss of func-
tion mutation in MAB21L1 in such a case12 Here, we identify 
homozygous variants in MAB21L1 in 10 affected members of 
5 consanguineous families who present with congenital under-
development of the labioscrotal folds in a similar overlapping 
clinical phenotype. The disease follows an autosomal recessive 
mode of inheritance in all families. Moderate-to-severe DD/
ID, behavioural abnormalities, severe cerebellar hypoplasia, a 
noticeably short forehead, medially sparse/flared and laterally 
extending eyebrows, corneal dystrophy, underdeveloped labio-
scrotal folds and tufts of hair extruding from the lactiferous ducts 
with breast and nipple underdevelopment are the main features. 
Additional features such as pontine involvement, retinal degen-
eration, anteverted nares and low set ears were variably observed 
in the affected individuals (table 1 and figure 2).
The mutations in MAB21L1 identified in this study as well 
as the previously identified variant in an additional family 
with a similar phenotype are frameshift/nonsense variants 
except one missense allele, most likely leading to complete loss 
of function of the protein, including loss of interactions with 
potential partner proteins. In mice, highest Mab21 expression 
levels have been detected in the rhombencephalon, cerebellum, 
midbrain and prospective neural retina.9 The precise function of 
MAB21L1 during embryonic development and how MAB21L1 
mutations cause COFG syndrome has not been established yet. 
However, Mab21l1 deficient mice and C. elegans show a pheno-
type relating to the human disease pattern with abnormalities 
noted in the brain, eyes, movement and reproductive organs. 
Specifically, abnormalities observed in loss-of function mouse 
models including impaired notochord and neural tube differenti-
ation, rudimentary lens, absence of iris and ciliary cells, preputial 
glands and calvarial osteogenesis4 show a pattern resembling the 
human COFG phenotype.
On the basis of conserved sequences of members of the MAB21 
protein family sharing over 90% aminoacid similarity, the family 
seems related to the larger family of nucleotidyltransferases 
(NTases) and MAB21L1 shares considerable sequence homology 
with the cyclic GMP-AMP synthase.6 However, Oliveira Mann 
et al suggested MAB21 has moderate binding to ssRNA, but they 
did not refute the NTase activity. In vitro, MAB21L1 seems to be 
able to oligimerise,6 to which extent this phenomena may also 
play a role in vivo has not been investigated to date. MAB21L1/2 
have a similar tissue expression pattern, bringing up the ques-
tion to which extend they may be functionally redundant. For 
human, our data argue against redundancy and suggest essential 
individual functions during development at least with relation to 
the eyes, the central nervous system (CNS), parts of the cranio-
facial and the genital tissues.
In C. elegans, it has been reported that Mab21 is negatively 
regulated by cet-1 (vertebrate BMP4)5 and likewise in Xenopus 
MAB21 suppresses BMP4, suggesting a role within or down-
stream of the TGF-ẞ pathway. Likewise, murine embryonic 
development and organogenesis indicate crucial involvement of 
Mab21l1 during eye development with high expression levels 
in both the optic vesicle as well as the lens placode, where its 
seems to act downstream of Bmp/FGF regulated PAX6 but 
upstream of Foxe3.4 In line with this, our String Network 
analysis (online supplementary figure S3)20 suggests that that 
MAB21L1 is connected to HOX, MEIS1-2 and PBX1-3 genes as 
well as LMX1B (online supplementary figure S3). Human muta-
tions in these putative interaction partners have been found to 
cause specific genetic syndromes including Myhre syndrome 
(OMIM#139210, SMAD4 variants), Hand-foot-genital 
by copyright.
 o
n
 M
ay 10, 2020 at Radboud University Nijmegen. Protected
http://jmg.bmj.com/
J M
ed G
enet: first published as 10.1136/jmedgenet-2018-105623 on 28 November 2018. Downloaded from 
338 Rad A, et al. J Med Genet 2019;56:332–339. doi:10.1136/jmedgenet-2018-105623
Developmental defects
syndrome (OMIM#140000, HOXA13 mutations) or Nail-pa-
tella syndrome (OMIM#161200, LMX1B dysfunction) and 
congenital malformation involving the skeleton, eye, genitals, 
kidney, heart and brain (BMP2, PAX6, MEIS2). Interestingly, 
these mutations have been found to be inherited in a predom-
inant autosomal dominant fashion in contrast to the recessive 
variants we identified in MAB21L1 (online supplementary table 
2). Regarding the potential role Mab21l1 may play for proper 
skeletal development, Kim et al further showed that activation 
of the JNK1/MKK4 pathway results in MEF phosphorylation 
and subsequent Mab21l1 activation in osteoblast cells.22
In summary, in this study, we confirm that biallelic MAB21L1 
loss-of-function mutations cause an extremely rare autosomal 
recessive recognisable syndrome, COFG syndrome. Likely, the 
developmental defects observed result at least partially from 
impaired TGF-beta/BMP and JNK1/MKK4 signalling; however; 
further functional studies regarding the characteristics observed 
in this syndrome will be required to determine the precise down-
stream cell signalling defects resulting from human MAB21L1 
loss of function variants.
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